Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 20, 2025Journal of Clinical MedicineOpen Access

Comprehensive Review of Lipid Management in Chronic Kidney Disease and Hemodialysis Patients: Conventional Approaches, and Challenges for Cardiovascular Risk Reduction

View Full Paper
Ask AI
Bookmark
Share

Authors

EAErica AbidorMAMichel Al AchkarISIbrahim Al Saidi

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abidor et al. (2025) studied this question.

synapsesocial.com/papers/6a0fa6d1fa36b6e053fcd130https://doi.org/10.3390/jcm14020643
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Do statins induce or protect from acute kidney injury and chronic kidney disease: An update review in 20182018 · 48 citations
  2. 2Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials2019 · 85 citations
  3. 3Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen)2022 · 14 citations
  4. 4Individualized Risk for Statin-Induced Myopathy: Current Knowledge, Emerging Challenges and Potential Solutions2012 · 67 citations
  5. 5Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial2019 · 214 citations